Nigeria Senate Fake Drugs Bill
Analysis based on 9 articles · First reported Jul 08, 2026 · Last updated Jul 09, 2026
The bill aims to curb counterfeit drugs, potentially boosting legitimate pharmaceutical businesses and public health. However, increased enforcement may raise compliance costs for drug manufacturers.
The Nigerian Senate passed for second reading the Counterfeit Medical Products, Fake Drugs and Unwholesome Processed Foods (Prohibition and Control) Bill, 2026, sponsored by Senator Suleiman Umar. The bill proposes up to 15 years imprisonment, asset forfeiture, fines, and victim compensation for counterfeit drug offenses. It strengthens NAFDAC's enforcement powers with tracking technology and establishes a multi-agency task force. The bill was referred to the Senate Committee on Health for further review.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard